» Articles » PMID: 17675306

Commentary: Measuring the Success of Blinding in RCTs: Don't, Must, Can't or Needn't?

Overview
Journal Int J Epidemiol
Specialty Public Health
Date 2007 Aug 7
PMID 17675306
Citations 44
Authors
Affiliations
Soon will be listed here.
Citing Articles

Methods to address functional unblinding of raters in CNS trials.

Targum S, Horan W, Davis V, Breier A, Brannan S Transl Psychiatry. 2025; 15(1):47.

PMID: 39920126 PMC: 11805955. DOI: 10.1038/s41398-025-03262-1.


'Which treatment do you believe you received?' A randomised blinding feasibility trial of spinal manual therapy.

Laguna J, Kurmann A, Hofstetter L, Nyantakyi E, Braun J, Clack L Chiropr Man Therap. 2025; 33(1):4.

PMID: 39810207 PMC: 11730787. DOI: 10.1186/s12998-024-00561-0.


A phase II trial examining the safety and preliminary efficacy of repetitive transcranial magnetic stimulation (rTMS) for people living with multiple sclerosis.

Stevens N, Ezegbe C, Fuh-Ngwa V, Makowiecki K, Zarghami A, Nguyen P Trials. 2024; 25(1):598.

PMID: 39245707 PMC: 11382484. DOI: 10.1186/s13063-024-08425-x.


Seeing the Truth About Double Blinding.

Redelmeier D, Zipursky J J Gen Intern Med. 2024; 39(16):3322-3329.

PMID: 39012541 PMC: 11618566. DOI: 10.1007/s11606-024-08887-4.


Low-intensity repetitive transcranial magnetic stimulation is safe and well tolerated by people living with MS - outcomes of the phase I randomised controlled trial (TAURUS).

Nguyen P, Zarghami A, Makowiecki K, Stevens N, Ezegbe C, Kyle K Mult Scler J Exp Transl Clin. 2024; 10(2):20552173241252571.

PMID: 38756414 PMC: 11097717. DOI: 10.1177/20552173241252571.